KAYLA HOLDER: Open Payments
NPI 1558182261 · COPPERHILL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $32 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ABBVIE INC. | 1 | $24 |
| Medtronic, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: Ozempic, GVOKE HYPOPEN, Rybelsus, AIRSUPRA, VRAYLAR, VENASEAL, CAPLYTA, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
